Agenus | AGEN - Betriebsaufwand

Aktienkurs
3.63
Täglich Wechseln
-0.06 -1.63%
Monatlich
12.38%
Jährlich
117.37%
Q1 Prognose
3.60




Betriebsaufwand Veränderung Datum
AbbVie USD 10.81B 13.45B 2025-12
Agenus USD 19.81M 293.94M 2025-12
Amgen USD 5.9B 773M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Celldex Therapeutics USD 87.27M 511.09M 2025-12
CSL USD 5.7B 2.82B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Glaxosmithkline GBP 9.17B 1.4B 2025-12
Incyte USD 1.12B 3.53B 2025-12
Intrexon USD 61.56M 26.1M 2024-06
J&J USD 18.97B 2.38B 2025-12
Jiangsu Hengrui CNY 5.94B 254.97M 2025-09
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
MacroGenics USD 53.32M 13.68M 2025-12
Merck EUR 4.78B 669M 2025-12
Merck USD 10.16B 558M 2025-12
Northwest Biotherapeutics USD -108.65M 8.26M 2025-09
Novartis USD 9.8B 61M 2025-12
Novavax USD 126.2M 23.62M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Veracyte USD 116M 7.24M 2025-12